255 related articles for article (PubMed ID: 23861929)
21. CYP17 gene polymorphisms and prostate cancer risk: a meta-analysis based on 38 independent studies.
Wang F; Zou YF; Feng XL; Su H; Huang F
Prostate; 2011 Aug; 71(11):1167-77. PubMed ID: 21656827
[TBL] [Abstract][Full Text] [Related]
22. CYP1B1 and predisposition to breast cancer in Poland.
Matyjasik J; Cybulski C; Masojć B; Jakubowska A; Serrano-Fernandez P; Górski B; Debniak T; Huzarski T; Byrski T; Gronwald J; Złowocka E; Narod SA; Scott R; Lubinski J
Breast Cancer Res Treat; 2007 Dec; 106(3):383-8. PubMed ID: 17458695
[TBL] [Abstract][Full Text] [Related]
23. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
[TBL] [Abstract][Full Text] [Related]
24. CYP1A1 and CYP1B1 genotypes, haplotypes, and TCDD-induced gene expression in subjects from Seveso, Italy.
Landi MT; Bergen AW; Baccarelli A; Patterson DG; Grassman J; Ter-Minassian M; Mocarelli P; Caporaso N; Masten SA; Pesatori AC; Pittman GS; Bell DA
Toxicology; 2005 Feb; 207(2):191-202. PubMed ID: 15596250
[TBL] [Abstract][Full Text] [Related]
25. Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma.
Bhattacharjee A; Banerjee D; Mookherjee S; Acharya M; Banerjee A; Ray A; Sen A; ; Ray K
Mol Vis; 2008 May; 14():841-50. PubMed ID: 18483560
[TBL] [Abstract][Full Text] [Related]
26. CYP1B1 Leu432Val polymorphism and colorectal cancer risk among Caucasians: a meta-analysis.
Xie Y; Liu GQ; Miao XY; Liu Y; Zhou W; Zhong DW
Tumour Biol; 2012 Jun; 33(3):809-16. PubMed ID: 22190224
[TBL] [Abstract][Full Text] [Related]
27. Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis.
Zhu HS; Zhang JF; Zhou JD; Zhang MJ; Hu HX
Genet Mol Res; 2015 Dec; 14(4):19329-41. PubMed ID: 26782586
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the CYP1B1 gene are associated with increased risk of prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner A; Hawkins GA; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Br J Cancer; 2003 Oct; 89(8):1524-9. PubMed ID: 14562027
[TBL] [Abstract][Full Text] [Related]
29. CYP1B1 C4326G polymorphism and susceptibility to cervical cancer in Chinese Han women.
Li Y; Tan SQ; Ma QH; Li L; Huang ZY; Wang Y; Li SW
Tumour Biol; 2013 Dec; 34(6):3561-7. PubMed ID: 23794133
[TBL] [Abstract][Full Text] [Related]
30. Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.
Mi Y; Zhang L; Feng N; Wu S; You X; Shao H; Dai F; Peng T; Qin F; Zou J; Zhu L
PLoS One; 2012; 7(9):e44756. PubMed ID: 23028604
[TBL] [Abstract][Full Text] [Related]
31. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN
Breast Cancer Res Treat; 2010 Jul; 122(2):545-51. PubMed ID: 20054638
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis.
Gajjar K; Owens G; Sperrin M; Martin-Hirsch PL; Martin FL
Toxicology; 2012 Dec; 302(2-3):157-62. PubMed ID: 23032576
[TBL] [Abstract][Full Text] [Related]
33. Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.
Rylander-Rudqvist T; Wedren S; Granath F; Humphreys K; Ahlberg S; Weiderpass E; Oscarson M; Ingelman-Sundberg M; Persson I
Carcinogenesis; 2003 Sep; 24(9):1533-9. PubMed ID: 12844487
[TBL] [Abstract][Full Text] [Related]
34. Lack of association of IL-10 gene polymorphisms with prostate cancer: evidence from 11,581 subjects.
Zou YF; Wang F; Feng XL; Tian YH; Tao JH; Pan FM; Huang F
Eur J Cancer; 2011 May; 47(7):1072-9. PubMed ID: 21211963
[TBL] [Abstract][Full Text] [Related]
35. Association Between the CYP1B1 Polymorphisms and Lung Cancer Risk: A Meta-Analysis.
Chen PF; He XF; Huang GH; Wang W; Qiu ZH
Technol Cancer Res Treat; 2016 Oct; 15(5):NP73-82. PubMed ID: 26283052
[TBL] [Abstract][Full Text] [Related]
36. Association of three 8q24 polymorphisms with prostate cancer susceptibility: evidence from a meta-analysis with 50,854 subjects.
Li Q; Liu X; Hua RX; Wang F; An H; Zhang W; Zhu JH
Sci Rep; 2015 Jul; 5():12069. PubMed ID: 26159557
[TBL] [Abstract][Full Text] [Related]
37. No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects.
Yao L; Fang F; Wu Q; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(1):237-42. PubMed ID: 20033481
[TBL] [Abstract][Full Text] [Related]
38. Association between endothelial nitric oxide synthase 894G>T polymorphism and prostate cancer risk: a meta-analysis of literature studies.
Zhao C; Yan W; Zu X; Chen M; Liu L; Zhao S; Liu H; Hu X; Luo R; Xia Y; Qi L
Tumour Biol; 2014 Dec; 35(12):11727-33. PubMed ID: 25374059
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.
Zhu S; Zhang H; Tang Y; Wang J
Urol Int; 2012; 89(2):233-40. PubMed ID: 22890093
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms in CYP1B1, GSTM1, GSTT1 and GSTP1, and susceptibility to breast cancer.
Van Emburgh BO; Hu JJ; Levine EA; Mosley LJ; Perrier ND; Freimanis RI; Allen GO; Rubin P; Sherrill GB; Shaw CS; Carey LA; Sawyer LR; Miller MS
Oncol Rep; 2008 May; 19(5):1311-21. PubMed ID: 18425393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
